Product details
Catalog number BNC741655-500
Price for BNC741655-500
Size / count 1x 500 µL
Expression of NKX2. 2 has been found in neuroendocrine tumors of the gut, making it a potential marker for the study of gastrointestinal neuroendocrine tumors. More recently, NKX2. 2 protein was identified as a target of EWS-FLI-1, the fusion protein specific to Ewing sarcoma, and was shown to be differentially upregulated in Ewing sarcoma on the basis of array-based gene expression analysis. It acts as a valuable marker for Ewing sarcoma, with a sensitivity of 93% and a specificity of 89%, and aids in the differential diagnosis of small round cell tumors. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for NKX2.2 (Neuroendocrine & Ewing's Sarcoma Marker), CF740 conjugate, 0.1mg/mL is BNC741655-500.
NKX2.2 (Neuroendocrine & Ewing's Sarcoma Marker), CF740 conjugate, 0.1mg/mL is available in the following size(s): 1x 500 µL.
NKX2.2 (Neuroendocrine & Ewing's Sarcoma Marker), CF740 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
NKX2.2 (Neuroendocrine & Ewing's Sarcoma Marker), CF740 conjugate, 0.1mg/mL is manufactured by Biotium.
Estimated delivery time for NKX2.2 (Neuroendocrine & Ewing's Sarcoma Marker), CF740 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for NKX2.2 (Neuroendocrine & Ewing's Sarcoma Marker), CF740 conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd02a5061270361e10580d/msds/bnc741655-500.pdf.
Expression of NKX2. 2 has been found in neuroendocrine tumors of the gut, making it a potential marker for the study of gastrointestinal neuroendocrine tumors. More recently, NKX2. 2 protein was identified as a target of EWS-FLI-1, the fusion protein specific to Ewing sarcoma, and was shown to be di
Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.
Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.
A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.